Literature DB >> 2898945

Serum biochemical and haematological markers of alcohol abuse in patients with femoral neck and intertrochanteric fractures.

C M Schnitzler1, L Menashe, C G Sutton, M B Sweet.   

Abstract

Excessive alcohol intake causes bone loss. Alcohol abuse is a commonly associated disorder in femoral neck fractures in men, but little attention is given to such an association in women. Using serum biochemical and haematological markers (mean red cell volume MCV, gamma-glutamyl transpeptidase GGT, aspartate transaminase AST, uric acid UA and triglyceride TG) alcohol abuse was assessed in 14 men and 93 women with non-violent fractures of the hip. Abnormal elevations in one or more of the five test pairs known to correlate with increasing alcohol consumption (GGT/MCV, GGT/AST, AST/MCV, MCV/UA) were found in 7.1% of men, and 11.8% of women. When abnormal results in other test pairs were included the prevalence rose to 14.3% in men and 20.4% in women. These figures are higher than those reported for the general population of elderly people.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2898945

Source DB:  PubMed          Journal:  Alcohol Alcohol        ISSN: 0735-0414            Impact factor:   2.826


  3 in total

1.  Cortical and trabecular bone microarchitecture and turnover in alcohol-induced chronic pancreatitis: a histomorphometric study.

Authors:  Christine M Schnitzler; Julia M Mesquita; Roy Shires
Journal:  J Bone Miner Metab       Date:  2010-01-26       Impact factor: 2.626

2.  Alcohol screening for older adults in an acute general hospital: FAST v. MAST-G assessments.

Authors:  Rachel Knightly; George Tadros; Juhi Sharma; Peter Duffield; Emma Carnall; Jacqui Fisher; Shaza Salman
Journal:  BJPsych Bull       Date:  2016-04

3.  Assessing the Usability of Web-Based Alcohol Education for Older Adults: A Feasibility Study.

Authors:  Arlene Fink; Lorna Kwan; Dan Osterweil; Jenna Van Draanen; Alexis Cooke; John C Beck
Journal:  JMIR Res Protoc       Date:  2016-02-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.